4
temporary balloon occlusion of the common hepatic artery for yttrium-90 glass microspheres administration in a patient with hepatocellular cancer and renal insufficiency.pdf
temporary balloon occlusion of the common hepatic artery for yttrium-90 glass microspheres administration in a patient with hepatocellular cancer and renal insufficiency
8
Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible_A Bi-institutional AnalysisAnnals of surgical oncolo.pdf
Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible_A Bi-institutional AnalysisAnnals of surgical oncolo ,Liver,After,with,liver,liv,after
4
microvascular injury in persistent gastric ulcers after yttrium-90 microsphere radioembolization for liver malignancies..微血管损伤在持久胃溃疡钇- 90微球肝malignancie.pdf
microvascular injury in persistent gastric ulcers after yttrium-90 microsphere radioembolization for liver malignancies..微血管损伤在持久胃溃疡钇- 90微球肝malignancie
7
Yttrium-90 delivered via a centering catheter and afterloader, given both before and after stent implantation, inhibits neointima formation in porcine coronary arteries.pdf
Yttrium-90 delivered via a centering catheter and afterloader, given both before and after stent implantation, inhibits neointima formation in porcine coronary arteries
6
Reduction of Metastatic Load to Liver after Intraarterial Hepatic Yttrium-90 Radioembolization as Evaluated by [18F]Fluorodeoxyglucose Positron Emission Tomographic Imaging.pdf
Reduction of Metastatic Load to Liver after Intraarterial Hepatic Yttrium-90 Radioembolization as Evaluated by [18F]Fluorodeoxyglucose Positron Emission Tomographic Imaging
5
a systematic review of yttrium-90 radioembolization for unresectable liver metastases of melanoma.[2017][eur j radiol][10.1016j.ejrad.2017.05.005].pdf
a systematic review of yttrium-90 radioembolization for unresectable liver metastases of melanoma.[2017][eur j radiol][10.1016j.ejrad.2017.05.005]
7
Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability.pdf
Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability

向豆丁求助:有没有yttrium-90?

如要投诉违规内容,请联系我们按需举报;如要提出意见建议,请到社区论坛发帖反馈。